Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 736 to 750 of 1372 results for social care

  1. Joint commissioning arrangements: What are the most effective joint commissioning arrangements for disabled children and young people with severe complex needs?

    complex needs: integrated service delivery and organisation across health, social care and education Number NG213 Date issued March 2022

    Research recommendation
    Published
    8 April 2022

  2. Gilteritinib for treating relapsed or refractory acute myeloid leukaemia (TA642)

    Evidence-based recommendations on gilteritinib (Xospata) for relapsed or refractory FLT3-mutation-positive acute myeloid leukaemia in adults.

    Technology appraisal guidance
    Published
    12 August 2020
    View recommendations

    Sections for TA642

  3. What community-based interventions are effective and cost effective at improving the uptake of, and reducing inequalities in the use of, dental services by groups of adults and children at high risk of poor oral health?

    Non-clinical outcomes should include the use of non-dental health and social care services by children and adults, such as numbers...

    Research recommendation
    Published
    9 June 2015

  4. One-piece closed bags for colostomies: late-stage assessment (HTE29)

    Late stage assessment (LSA) guidance on one-piece closed bags for colostomies....

    Health technology evaluation
    Published
    10 July 2025
    View recommendations

    Sections for HTE29

  5. Physical activity: for NHS staff, patients and carers (QS84)

    This quality standard covers encouraging physical activity in people of all ages who are in contact with the NHS, including staff, patients and carers. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    25 March 2015
    View quality statements

    Sections for QS84

  6. Mollii suit for spasticity (MIB100)

    NICE has a developed medtech innovation briefing on Mollii suit for spasticity .

    Medtech innovation briefing
    Published
    28 March 2017

  7. The consequences and costs of poor transition:- What are the consequences and the costs of young people with ongoing needs not making a transition into adult services, or being poorly supported through the process?

    from children's to adults' services for young people using health or social care services Number NG43 Date issued February 2016

    Research recommendation
    Published
    21 March 2016

  8. Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea (TA777)

    Evidence-based recommendations on solriamfetol (Sunosi) for treating excessive daytime sleepiness caused by obstructive sleep apnoea in adults.

    Technology appraisal guidance
    Published
    9 March 2022
    View recommendations

    Sections for TA777

  9. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (TA151)

    Evidence-based recommendations on continuous subcutaneous insulin infusion (insulin pump therapy) for treating type 1 diabetes in adults and children.

    Technology appraisal guidance
    Published
    23 July 2008
    View recommendations

    Sections for TA151

  10. Berotralstat for preventing recurrent attacks of hereditary angioedema (TA738)

    Evidence-based recommendations on berotralstat (Orladeyo) for preventing recurrent attacks of hereditary angioedema in people 12 years and older.

    Technology appraisal guidance
    Published
    20 October 2021
    View recommendations

    Sections for TA738

  11. Supporting young people to manage their conditions:- What is the relationship between transition and subsequent self-management?

    from children's to adults' services for young people using health or social care services Number NG43 Date issued February 2016

    Research recommendation
    Published
    21 March 2016

  12. Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over (HST33)

    Evidence-based recommendations on leniolisib (Joenja) for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over.

    Highly specialised technologies guidance
    Published
    23 April 2025

    Sections for HST33

  13. Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)

    Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection

    Evidence summary
    Published
    17 March 2015

  14. What training, support or interventions help to reduce caring-related accidents or incidents?

    understanding of the health condition, disability or needs of the person they care for, so the committee recommended carer-specific...

    Research recommendation
    Published
    10 February 2020

  15. Balloon disimpaction of the baby's head at emergency caesarean during the second stage of labour (IPG800)

    Evidence-based recommendations on balloon disimpaction of the baby’s head at emergency caesarean during the second stage of labour. This involves inserting a silicone balloon into the vagina and inflating to lift the baby’s head before starting the caesarean.

    Interventional procedures guidance
    Published
    23 April 2025
    View recommendations

    Sections for IPG800